《大行報告》花旗上調上石化(00338.HK)目標價至2.6元 評級「買入」
花旗發表報告指,上石化(00338.HK)發盈警,預期去年純利按年下跌69%至74%,到5.66億至6.92億元人民幣,意味去年第四季純利約13億元人民幣,按年增長135%,按季增長18%。
該行表示,季度盈利勢頭強勢,相信是由存貨收益及化工品價差大所推動,若杜拜原油至本季尾價格可維持在目前的每桶55美元水平,集團預計將再獲每桶3美元的存貨收益。
花旗上調上石化股份目標價,由2.11元升至2.6元,評級維持「買入」,並調升集團2020年至2022年盈利預測分別222%、27%及16%,以反映去年第四季更強的盈利表現及存貨收益,加上今明兩年有更佳的化工品價差。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.